Favorable response to doxorubicin combination chemotherapy does not yield good clinical outcome in patients with metastatic breast cancer with triple-negative phenotype

BACKGROUND: We analyzed the responses to first line treatment and clinical outcomes of metastatic breast cancer patients treated with palliative doxorubicin/cyclophosphamide (AC) according to molecular cancer subtype. METHODS: A retrospective analysis was performed for 110 metastatic breast cancer p...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Autori principali: Yi, Seong Yoon, Ahn, Jin Seok, Uhm, Ji Eun, Lim, Do Hyoung, Ji, Sang Hoon, Jun, Hyun Jung, Kim, Kyoung Ha, Chang, Myung Hee, Park, Min Jae, Cho, Eun Yoon, La Choi, Yoon, Park, Yeon Hee, Im, Young-Hyuck
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2010
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC2972282/
https://ncbi.nlm.nih.gov/pubmed/20920367
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-10-527
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi